福泰製藥 VRTX 深 滬
已收盤 09-12 16:00:00 美东时间
394.53
-2.840
-0.71%
華盛通- 最 高396.83
- 今 開394.68
- 成交量 97.87万股
- 最 低 393.17
- 昨 收 397.37
- 總市值 1013.94亿
- 52周最高 519.88
- 市盈率 靜 --
- 換手率 0.38%
- 52周最低 362.50
- 委 比 -71.55%
- 總股本 2.57亿
- 歷史最高 519.88
- 量 比 0.77
- 振 幅 0.92%
- 歷史最低 26.50
- 每 手 1
- 風險率 42.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Vor Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum
<p>Vor Bio, a clinical-stage biotechnology company focused on autoimmune diseases, announced its participation in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on September 15, 2025. The event will also include virtual 1x1 investor meetings. A live webcast and replay of the fireside chat will be available on the Company’s website at [https://ir.vorbio.com/events-presentations/](https://ir.vorbio.com/events-presentat...
09-12 20:15
美股大行评级 | 潜在涨幅208.48%！HC Wainwright & Co.上调Microbot Medical目标价至12美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Microbot Medical"买入"评级，目标价从9美元升至12美元；Maxim Group：维持Neuphoria Therapeutics"买入"评级，目标价从18美元升至35美元
09-12 12:53
“诺奖风向标”之称的拉斯克奖揭晓！一位获奖者曾获首届世界顶尖科学家协会奖
（来源：上观新闻） 北京时间9月11日晚，被誉为“诺奖风向标”的生物医学领域重要奖项——拉斯克奖正式揭晓。 德国马克斯·普朗克研究所迪尔克...
09-12 11:27
Evercore ISI Group Maintains Outperform on Vertex Pharmaceuticals, Lowers Price Target to $475
Evercore ISI Group analyst Liisa Bayko maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperform and lowers the price target from $510 to $475.
09-11 21:53
Vornado Completes Acquisition of 623 Fifth Avenue
Vornado Realty Trust has completed the acquisition of the 623 Fifth Avenue office condominium for $218 million. The 36-story, 382,500 rentable square foot building is currently 75% vacant and will be repositioned and redeveloped into a premier Class A boutique office building.
09-08 20:29
Vertex to Present at Goldman Sachs Communacopia + Technology Conference
Vertex, Inc. (NASDAQ: VERX), a global provider of tax technology solutions, announced that its CEO, David DeStefano, and CFO, John Schwab, will participate in a fireside chat at the Goldman Sachs Communacopia + Technology Conference on September 11, 2025, at 9:30 AM Pacific Time. A live webcast and replay of the presentation will be available on Vertex’s investor relations website at ir.vertex.com. Vertex specializes in indirect tax solutions, em...
09-08 11:00
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics granted inducement awards, including stock options for 85,000 shares and RSUs for 45,250 shares, to eight new employees on September 4, 2025. The stock options have an exercise price of $21.90 per share, vesting over four years. RSUs also vest over four years. The awards align with Vera's 2024 Inducement Plan and Nasdaq rules. Vera focuses on developing treatments for immunological diseases with its lead product, atacicept, and ...
09-05 20:05
Verizon boosts shareholder payout, marking 19th consecutive year of dividend growth
<p>Verizon Communications Inc. announced a quarterly dividend increase to 69 cents per share, marking the 19th consecutive annual raise. This reflects disciplined financial management and strategic network expansion. The dividend will be paid on November 3 to shareholders of record as of October 10. Verizon distributed over $11.2 billion in dividends in 2024, showcasing its commitment to shareholder value.</p>
09-05 15:18
福泰制药融投科技：以实际行动回馈社会，践行企业社会责任
福泰制药融投科技（香港）有限公司总部在香港，成立于2025年，定位为母公司在亚太地区的资本与战略枢纽，主要承担Vertex在区域内的投融资、市场拓展与战略合作职...
09-05 10:07
